Standard Chemical & Pharmaceutical Co. Ltd. (TPE: 1720)

Market Cap	11.53B
Revenue (ttm)	6.61B
Net Income (ttm)	854.07M
Shares Out	178.70M
EPS (ttm)	4.78
PE Ratio	13.50
Forward PE	n/a
Dividend	2.70 (4.24%)
Ex-Dividend Date	Aug 1, 2024

Volume	2,000
Open	64.30
Previous Close	64.50
Day's Range	64.10 - 64.30
52-Week Range	58.10 - 79.40
Beta	0.13
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 5, 2024

About Standard Chemical & Pharmaceutical

Standard Chemical & Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, supplements, and APIs in Taiwan. It offers various pharmaceutical products, including circulatory system, digestive system, respiratory system, antihistamine, C.N.S, metabolism, anti-microbial, and skin and mucous membrane drugs, as well as human and veterinary APIs, and excipients. The company was founded in 1967 and is headquartered in Tainan City, Taiwan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1967
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 1720

Financial Performance

In 2023, Standard Chemical & Pharmaceutical's revenue was 6.24 billion, an increase of 6.64% compared to the previous year's 5.85 billion. Earnings were 834.89 million, an increase of 2.39%.